Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Aims of talk
3. Bronchiectasis (1)
4. Pathophysiology
5. Bronchiectasis (2)
6. Mucociliary clearance mechanism
7. Chronic airways infection (1)
8. Chronic airways infection (2)
9. Chronic airways inflammation
10. Chronic colonisation and inflammation
11. Vicious cycle of inflammation and infection
12. Aetiology (1)
13. Aetiology (2)
14. Aetiology: incidence rates
15. Prevalence and burden
16. Bronchiectasis: prevalence and burden
17. Clinical features
18. Symptoms and signs
19. Diagnosis
20. Diagnosis: methods and defining features
21. Characteristics by disease severity
22. Management
23. Management of chronic bronchiectasis
24. Goals of management
25. A multi-faceted approach to management
26. Patient education (1)
27. Patient education (2)
28. Airway clearance
29. Airway clearance: techniques
30. Chest physiotherapy: aims
31. Chest physiotherapy: results
32. Chest physiotherapy: techniques
33. Physiotherapy techniques in clinical trials
34. Pulmonary rehabilitation: clinical trials
35. Pulmonary rehabilitation: results
36. Nebulised saline and beta-2 agonists
37. Nebulised saline
38. rhDNase: clinical trials & results
39. Mannitol: clinical trials & results
40. Inhaled corticosteroids: clinical trials
41. Inhaled corticosteroids: results
42. Airway clearance: recommendations in practice
43. Long term strategies: anti-inflammatories
44. Anti-inflammatories
45. Long term strategies: antimicrobials
46. Long term antibiotics: aims and techniques
47. Long term oral antibiotics: clinical trials
48. Long term nebulised antibiotics- clinical trials (1)
49. Long term nebulised antibiotics- clinical trials (2)
50. Long term oral antibiotics: recommendations
51. Long term nebulised antibiotics: recommendations
52. Long term strategies: eradication of organisms
53. Eradication of organisms
54. Long term strategies: surgery
55. Surgery
56. Management: summary
57. Future

Topics Covered

• Non-cystic fibrosis bronchiectasis
• A vicious cycle of chronic airways infection and inflammation
• Significant clinical and socioeconomic morbidity
• Crucial to try to establish and treat any underlying aetiology
• Disease severity should be assessed
• Long term management is multifaceted and includes airway clearance techniques, anti-inflammatory strategies and antimicrobial strategies

Links

Series:

• Respiratory Infection

Categories:

• Clinical Practice
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Smith, M.P. (2013, July 11). An overview of non-cystic fibrosis bronchiectasis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/PDRJ8559.
Export Citation (RIS)

Publication History

• Published on July 11, 2013

Financial Disclosures

• Dr. Maeve P. Smith has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.